A review of health-economic models for CVD screening reveals significant methodological heterogeneity and highlights the need for improved model validation, uncertainty incorporation, and consideration of budget impact.
No takes yet. Share an insight, caveat, or question.
Future CVD screening models must resolve these issues before informing European practice; leaves open optimal primary prevention strategies.
Epstein et al. (2015) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: